Clinical Trial: Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Psychological Morbidity and Facial Volume in HIV Lipodystrophy:

Brief Summary:

The hypotheses of this study were that:

  1. HIV lipodystrophy is associated with psychological morbidity relating to body image, anxiety and depression.
  2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical volume of treated areas.
  3. The DI3D system is a valid and reproducible method of recording and measuring facial 3-D volume.

Detailed Summary: as above
Sponsor: NHS Lothian

Current Primary Outcome: measurement of 3-D facial volume [ Time Frame: 2 years ]

3-D facial camera


Original Primary Outcome: measrement of 3-D facial volume [ Time Frame: 2 years ]

3-D facial camera


Current Secondary Outcome: psychological outcome [ Time Frame: 2 years ]

derriford appearance scale hospital anxiety and depression scale


Original Secondary Outcome: Same as current

Information By: NHS Lothian

Dates:
Date Received: May 23, 2011
Date Started: August 2006
Date Completion:
Last Updated: June 9, 2011
Last Verified: March 2006